Bardin Hill Management Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Bardin Hill Management Partners's ONCE Position: Q4 2019 in Review
Bardin Hill Management Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 27,226 shares — an estimated $2.64M sold.
Bardin Hill Management Partners first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $17.4M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Bardin Hill Management Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Bardin Hill Management Partners sold 27,226 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.64M.
- Bardin Hill Management Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
- Bardin Hill Management Partners's Spark Therapeutics, Inc. Common Stock position peaked at $17.4M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Bardin Hill Management Partners's 13F filing for Q4 2019, filed 14 Feb 2020.